This page lists the SEC filings reported by Birchview Capital, LP.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-20 | Birchview Capital, LP | ELUTIA INC. | 1,655,184 | 8.8% | EDGAR |
SC 13G/A | 2023-04-07 | Birchview Capital, LP | AZIYO BIOLOGICS, INC. | 1,655,184 | 13.9% | EDGAR |
SC 13G/A | 2023-02-13 | Birchview Capital, LP | AZIYO BIOLOGICS, INC. | 1,515,184 | 12.8% | EDGAR |
SC 13G/A | 2022-12-15 | Birchview Capital, LP | AZIYO BIOLOGICS, INC. | 1,502,123 | 12.7% | EDGAR |
SC 13G | 2021-12-17 | Birchview Capital, LP | AZIYO BIOLOGICS, INC. | 1,417,923 | 15.3% | EDGAR |
SC 13G/A | 2019-03-19 | Birchview Capital, LP | SOLENO THERAPEUTICS INC | 742,635 | 2.3% | EDGAR |
SC 13D/A | 2017-12-29 | Birchview Capital, LP | YIELD10 BIOSCIENCE, INC. | 186,079 | 2.2% | EDGAR |
SC 13G | 2017-12-26 | Birchview Capital, LP | SOLENO THERAPEUTICS INC | 1,180,463 | 6.2% | EDGAR |
SC 13G/A | 2016-02-16 | Birchview Capital, LP | HANSEN MEDICAL INC | - | - | EDGAR |
SC 13D/A | 2015-06-23 | Birchview Capital, LP | METABOLIX, INC. | 749,696 | 2.8% | EDGAR |
SC 13G | 2015-03-19 | Birchview Capital, LP | HANSEN MEDICAL INC | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.